OBJECTIVE: The purpose of this study was to determine if preeclampsia is associated with a reduced risk of cancer later in life. STUDY DESIGN: We performed a cohort study where women with preeclampsia over the interval 1947 to 1999 were identified from the Utah Population Database. Preeclamptics (n = 17,432) were matched 1:3 with nonpreeclamptics (n = 52,296) on maternal age and birth year. Pregnancy, demographic, and cancer information was extracted from subjects and their offspring in linked datasets. Relative risk and hazard ratios were calculated. RESULTS: In a matched analysis using univariable random-effects Poisson regression, preeclampsia was protective against the development of cancer later in life (RR 0.91, 95% CI 0.84-0.99 with P = .027). In a multivariable clustered Cox regression model with the end point of cancer later in life, preeclampsia was associated with a lower risk of cancer (HR 0.92, 95% CI 0.85-0.99 with P = .039). These findings were supported by stratified and competing risk analyses. CONCLUSION: Women whose pregnancies were affected by preeclampsia have a decreased risk of developing cancer.
OBJECTIVE: The purpose of this study was to determine if preeclampsia is associated with a reduced risk of cancer later in life. STUDY DESIGN: We performed a cohort study where women with preeclampsia over the interval 1947 to 1999 were identified from the Utah Population Database. Preeclamptics (n = 17,432) were matched 1:3 with nonpreeclamptics (n = 52,296) on maternal age and birth year. Pregnancy, demographic, and cancer information was extracted from subjects and their offspring in linked datasets. Relative risk and hazard ratios were calculated. RESULTS: In a matched analysis using univariable random-effects Poisson regression, preeclampsia was protective against the development of cancer later in life (RR 0.91, 95% CI 0.84-0.99 with P = .027). In a multivariable clustered Cox regression model with the end point of cancer later in life, preeclampsia was associated with a lower risk of cancer (HR 0.92, 95% CI 0.85-0.99 with P = .039). These findings were supported by stratified and competing risk analyses. CONCLUSION:Women whose pregnancies were affected by preeclampsia have a decreased risk of developing cancer.
Authors: Jessica M Faupel-Badger; Thomas F McElrath; Michele Lauria; Lauren C Houghton; Kee-Hak Lim; Samuel Parry; David Cantonwine; Gabriel Lai; S Ananth Karumanchi; Robert N Hoover; Rebecca Troisi Journal: Am J Obstet Gynecol Date: 2014-11-27 Impact factor: 8.661
Authors: Rebecca Troisi; Anne Gulbech Ording; Tom Grotmol; Ingrid Glimelius; Anders Engeland; Mika Gissler; Britton Trabert; Anders Ekbom; Laura Madanat-Harjuoja; Henrik Toft Sørensen; Steinar Tretli; Tone Bjørge Journal: Int J Cancer Date: 2018-08-10 Impact factor: 7.396
Authors: R Troisi; T Bjørge; M Gissler; T Grotmol; C M Kitahara; S M Myrtveit Saether; A G Ording; C Sköld; H T Sørensen; B Trabert; I Glimelius Journal: J Intern Med Date: 2018-03-25 Impact factor: 8.989
Authors: Rosie Cornish; Anne Cathrine Staff; Andy Boyd; Debbie A Lawlor; Steinar Tretli; Gary Bradwin; Thomas F McElrath; Marianne Hyer; Robert N Hoover; Rebecca Troisi Journal: Cancer Causes Control Date: 2018-12-01 Impact factor: 2.506
Authors: Zahra Pasdar; David T Gamble; Phyo K Myint; Robert N Luben; Nicholas J Wareham; Kay-Tee Khaw; Sohinee Bhattacharya Journal: Cancers (Basel) Date: 2020-10-23 Impact factor: 6.639